Fibromyalgia: A Brain Problem, Not “Just Pain”
Fibromyalgia is not a mysterious pain condition without a cause. It is a measurable disorder of central pain processing—a brain that has learned to amplify sensory signals far beyond what the incoming stimulus warrants. When you treat the brain, you change the pain.
The Neurology of Fibromyalgia
For decades, fibromyalgia occupied an uncomfortable gray zone in medicine. Patients reported debilitating pain, crushing fatigue, and cognitive dysfunction that could not be explained by conventional lab work or imaging. Many were told the problem was psychological. Some were told they were exaggerating. A diagnosis of fibromyalgia was, in practice, a diagnosis of “we don’t know.”
That era is over. Over the past fifteen years, neuroimaging research has demonstrated that fibromyalgia is a disorder of central sensitization—a state in which the central nervous system amplifies pain signals and lowers the threshold at which stimuli are perceived as painful. This is not a metaphor. It is visible on functional brain imaging. Napadow et al. (2010), publishing in Arthritis & Rheumatism, used functional MRI to show that fibromyalgia patients display increased connectivity between the default mode network and the insula—a brain region central to pain processing. The result is a nervous system that treats normal sensory input as threatening.
Clauw (2014), writing in JAMA, synthesized two decades of research into a clinical framework: fibromyalgia belongs to a family of central sensitivity syndromes in which the brain and spinal cord process sensory information abnormally. Pain is real. It is generated centrally. And it can be measured, mapped, and treated once the diagnostic framework shifts from peripheral tissue to the central nervous system.
This reframing matters because it changes everything about how the condition should be evaluated and managed. Searching for inflammation in the joints or muscles of a fibromyalgia patient misses the point entirely. The problem is not in the tissue. The problem is in the brain’s interpretation of the tissue.
Why Standard Treatment Falls Short
The conventional approach to fibromyalgia relies on a narrow pharmacological toolkit. Pregabalin modulates calcium channels. Duloxetine adjusts serotonin and norepinephrine reuptake. Gabapentin dampens excitatory signaling. These medications can reduce symptom intensity for some patients, but they do not address the metabolic environment that created the central sensitization in the first place. For many patients, the side effects—weight gain, cognitive blunting, drowsiness—compound the very problems they were prescribed to solve.
What is almost never assessed in a standard fibromyalgia workup is the metabolic infrastructure of the nervous system itself. Mitochondrial dysfunction is consistently documented in fibromyalgia patients. Cordero et al. (2010), publishing in Clinical Biochemistry, found reduced coenzyme Q10 levels and impaired mitochondrial function in fibromyalgia patients compared to controls—findings that correlated directly with symptom severity. When the cells responsible for processing sensory information cannot produce adequate energy, the system defaults to a hypervigilant state. Pain thresholds drop. Fatigue increases. Cognition suffers.
Oxidative stress compounds the problem. Neurons under chronic metabolic strain generate excessive reactive oxygen species that damage cell membranes, mitochondrial DNA, and neurotransmitter receptors. Without adequate antioxidant defenses—particularly glutathione, the brain’s primary endogenous antioxidant—this damage accumulates. The result is a self-reinforcing cycle: metabolic dysfunction drives oxidative stress, oxidative stress worsens metabolic dysfunction, and the central nervous system remains locked in a sensitized state.
Our Diagnostic Approach
Fibromyalgia is a clinical diagnosis, but that does not mean the workup should stop at a tender point count. At The Neurogenesis Project, we evaluate fibromyalgia through the lens of neurology—mapping both the functional state of the brain and the metabolic environment that sustains it.
We begin by ruling out conditions that mimic or overlap with fibromyalgia: autoimmune disorders such as lupus and rheumatoid arthritis, thyroid dysfunction, sleep disorders including obstructive sleep apnea, and vitamin deficiencies that affect neurological function. These are not rare. They are common enough that missing one can mean treating the wrong condition entirely.
Advanced neuroimaging—including MRI and, when clinically indicated, PET scanning—allows us to evaluate regional brain metabolism and structural integrity. PET scanning can reveal patterns of hypometabolism in brain regions involved in pain processing and executive function, providing objective data that goes beyond subjective symptom reports.
Our brain health lab panel measures inflammatory cytokines, markers of oxidative stress, mitochondrial function indicators, neurotransmitter metabolites, hormonal levels, and nutrient cofactors. The goal is not to confirm a fibromyalgia diagnosis the patient already has. It is to identify the specific metabolic and inflammatory drivers behind that individual’s presentation so that treatment targets the right mechanisms. Learn more about our laboratory approach on our brain health lab panels page.
Treatment Approach
Our fibromyalgia protocols target the metabolic dysfunction and oxidative stress that sustain central sensitization, rather than masking symptoms with pharmaceuticals alone.
NAD+ IV Therapy
Nicotinamide adenine dinucleotide is the central coenzyme in mitochondrial energy production. In fibromyalgia patients with documented mitochondrial dysfunction, IV NAD+ restores the substrate neurons need to produce ATP efficiently. When cellular energy normalizes, pain thresholds rise and cognitive function improves.
Glutathione IV Therapy
Glutathione is the brain’s primary endogenous antioxidant. Chronic pain states deplete glutathione reserves, leaving neurons vulnerable to oxidative damage that perpetuates the sensitization cycle. IV glutathione bypasses the limitations of oral supplementation and delivers therapeutic concentrations directly to the tissues that need it most.
Myers’ Cocktail IV Therapy
This IV formulation delivers magnesium, B-complex vitamins, calcium, and vitamin C at concentrations that oral supplementation cannot achieve. Magnesium plays a direct role in NMDA receptor modulation—the same receptor system implicated in central sensitization. B vitamins support neurotransmitter synthesis and myelin maintenance.
NeuroCoaching
Dr. Drew Edwards works directly with fibromyalgia patients to build individualized strategies for pain management, sleep architecture restoration, stress response regulation, and cognitive resilience. NeuroCoaching addresses the behavioral and environmental factors that either sustain or interrupt the central sensitization cycle.
Exosome Therapy
Extracellular vesicles derived from mesenchymal stem cells carry anti-inflammatory signaling molecules, growth factors, and regulatory microRNAs. In patients with elevated neuroinflammatory markers, exosome therapy delivers targeted immunomodulation that can reduce the inflammatory load contributing to pain amplification.
Brain Health Lab Panels
Comprehensive metabolic, inflammatory, and hormonal testing identifies the specific biochemical drivers behind each patient’s fibromyalgia presentation. These labs guide every treatment decision and provide objective benchmarks for tracking improvement over time.
Related Treatments
Chronic Pain: Neurological Approach
Chronic pain conditions share overlapping mechanisms with fibromyalgia, including central sensitization and neuroinflammation. Our diagnostic and treatment approach addresses pain at its neurological source.
Brain Fog Treatment
Cognitive dysfunction in fibromyalgia—“fibro fog”—responds to the same metabolic interventions that address the pain component. Restoring mitochondrial function and reducing oxidative stress often improves both simultaneously.
Fatigue: Neurological Evaluation
The fatigue associated with fibromyalgia has the same metabolic root as the pain—mitochondrial dysfunction and chronic neuroinflammation. Treating the underlying metabolic state addresses fatigue and pain as parts of the same problem.
Frequently Asked Questions
Is fibromyalgia really a brain disorder?+
What diagnostic testing do you use for fibromyalgia?+
What treatments do you offer for fibromyalgia?+
How is your approach different from what a rheumatologist does?+
Can fibromyalgia be cured?+
How long does the evaluation and treatment take?+
Fibromyalgia Deserves a Neurological Evaluation
If you’ve been told your labs are normal and your pain is “just fibromyalgia,” you have not yet had the right workup. Central sensitization is a neurological problem with neurological solutions. Dr. Orr and the team at The Neurogenesis Project are evaluating fibromyalgia patients in St. Marys, Georgia.